ArticleScientific reports2025
Prevalence and distribution of Plasmodium falciparum multidrug resistant 1 D1246Y allele among children in Ibadan Southwest, Nigeria.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Incidence of kelch13 and Pfmdr1 gene mutations associated with antimalarial drug resistance in Plasmodium falciparum isolates from Ethiopia: a systematic review and meta-analysis.BMC infectious diseases · 2026Pooled it
- Molecular Surveillance ofPathogens (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The emergence and spread of the Plasmodium falciparum multidrug-resistant 1 (Pfmdr1) allele pose a significant setback to global efforts to control and eradicate malaria infection by diminishing the efficacy of commonly prescribed antimalarial drugs, particularly in Sub-Saharan Africa, where malaria remains endemic. The Pfmdr1 D1246Y mutation is of specific importance due to its potential role in modulating parasite susceptibility to antimalarial medicines and treatment outcomes. This study aimed to determine the presence and prevalence of the wild-type and mutant D1246Y alleles of Pfmdr1 among children in Ibadan, Southwest Nigeria. A total of 133 archived DNA samples collected between March 2016 and June 2021 from children aged 6 to 132 months with varying malaria phenotypes (asymptomatic infection, uncomplicated, and severe malaria) were analyzed. The Pfmdr1 D1246Y allele was amplified via nested PCR, and the mutation was detected using the restriction enzyme EcoRV. The digested nested PCR products were resolved on a 2% agarose gel and visualized under ultraviolet light. All statistical analyses were performed using SPSS version 25, and statistical significance was set at p ≤ 0.05. Among the 133 samples, 97 (72.9%) were successfully genotyped. Of these, 50 (51.55%) carried the wild-type allele, while 47 (48.45%) had the mutant allele. Notably, the Pfmdr1-1246Y mutation was detected in all severe malaria cases (41/41, 100%), whereas its prevalence was significantly lower in asymptomatic (3/36, 8.3%) and uncomplicated malaria cases (3/20, 15%). The difference in mutation prevalence across the malaria phenotypes was statistically significant (p < 0.05). The study provided valuable insight into the coexistence of wild-type and mutant Pfmdr1 D1246Y alleles within the population. It revealed a significantly higher mutation rate in all severe malaria cases, while the wild-type allele remained more prevalent overall. These findings contribute to a deeper understanding of the possible role of the wild-type and mutant D1246Y alleles in the various clinical manifestations of malaria.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.